• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲非酒精性脂肪性肝病患者的不健康生活方式习惯及缺乏身体活动情况。

Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease.

作者信息

Zhang Xinrong, Goh George B-B, Chan Wah-Kheong, Wong Grace L-H, Fan Jian-Gao, Seto Wai-Kay, Huang Yi-Hsiang, Lin Han-Chieh, Lee I-Cheng, Lee Hye Won, Kim Seung Up, Chow Wan Cheng, Wong Vincent W-S

机构信息

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Liver Int. 2020 Nov;40(11):2719-2731. doi: 10.1111/liv.14638. Epub 2020 Oct 13.

DOI:10.1111/liv.14638
PMID:32799384
Abstract

BACKGROUND & AIMS: Lifestyle modification is the cornerstone for the management of non-alcoholic fatty liver disease (NAFLD). We aim to understand lifestyle habits of NAFLD patients, compare across Asian regions and identify area of deficiency.

METHODS

In the multi-centre controlled attenuation parameter (CAP)-Asia study, we collected clinical data and lifestyle habit data of NAFLD patients from Singapore, mainland China, Hong Kong, Taiwan and Malaysia. Physical activity was assessed using the International Physical Activity Questionnaire.

RESULTS

A total of 555 patients were included in the final analysis (mean age 54.5 ± 11.2 years, 54.1% men and median liver stiffness 6.7 kPa). More patients from mainland China (27.4%) and Taipei (25.0%) were smokers. Modest drinking was more common in Taiwan (25.0%) and Hong Kong (18.2%); only 1.3% had binge drinking. Majority of patients drank coffee (64.0%) and tea (80.2%), with varying amounts and durations in different regions. Soft drinks consumption was most common in Singapore (62.2%) and Malaysia (57.7%). Only 29.7% of patients met the Physical Activity Guidelines Recommendations, with no major differences across regions. Patients with liver stiffness <10 kPa were more likely to report any vigorous activity, and sitting time was an independent factor associated with high CAP. Tea and coffee consumption were independently associated with high CAP and liver stiffness, respectively.

CONCLUSIONS

Despite some heterogeneity, unhealthy lifestyle and physical inactivity are common across Asian regions. Patients with liver stiffness <10 kPa were more likely to report any vigorous activity. Healthcare providers may use the comparative data to identify areas of deficiency.

摘要

背景与目的

生活方式改变是非酒精性脂肪性肝病(NAFLD)管理的基石。我们旨在了解NAFLD患者的生活习惯,比较亚洲不同地区的情况,并确定不足之处。

方法

在多中心控制衰减参数(CAP)-亚洲研究中,我们收集了来自新加坡、中国大陆、香港、台湾和马来西亚的NAFLD患者的临床数据和生活习惯数据。使用国际体力活动问卷评估体力活动情况。

结果

共有555例患者纳入最终分析(平均年龄54.5±11.2岁,男性占54.1%,肝硬度中位数为6.7 kPa)。中国大陆(27.4%)和台北(25.0%)的吸烟者较多。适度饮酒在台湾(25.0%)和香港(18.2%)更为常见;只有1.3%的人有暴饮行为。大多数患者喝咖啡(64.0%)和茶(80.2%),不同地区的饮用量和饮用时间各不相同。软饮料消费在新加坡(62.2%)和马来西亚(57.7%)最为普遍。只有29.7%的患者达到体力活动指南建议,各地区之间无显著差异。肝硬度<10 kPa的患者更有可能报告进行任何剧烈活动,久坐时间是与高CAP相关的独立因素。茶和咖啡消费分别与高CAP和肝硬度独立相关。

结论

尽管存在一些异质性,但不健康的生活方式和缺乏体育活动在亚洲各地区都很常见。肝硬度<10 kPa的患者更有可能报告进行任何剧烈活动。医疗保健提供者可以利用这些比较数据来确定不足之处。

相似文献

1
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease.亚洲非酒精性脂肪性肝病患者的不健康生活方式习惯及缺乏身体活动情况。
Liver Int. 2020 Nov;40(11):2719-2731. doi: 10.1111/liv.14638. Epub 2020 Oct 13.
2
Modelling NAFLD disease burden in four Asian regions-2019-2030.2019 - 2030年四个亚洲地区非酒精性脂肪性肝病疾病负担建模
Aliment Pharmacol Ther. 2020 Apr;51(8):801-811. doi: 10.1111/apt.15673. Epub 2020 Mar 4.
3
A comparison of factors associated with physical inactivity among East Asian college students.比较与东亚大学生身体活动不足相关的因素。
Int J Behav Med. 2012 Sep;19(3):316-23. doi: 10.1007/s12529-011-9167-4.
4
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
5
Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.香港非酒精性脂肪肝疾病的发病率:一项配对质子磁共振波谱的人群研究。
J Hepatol. 2015 Jan;62(1):182-9. doi: 10.1016/j.jhep.2014.08.041. Epub 2014 Sep 6.
6
Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.疾病认知和自我效能在非酒精性脂肪性肝病患者生活方式改变中的作用。
World J Gastroenterol. 2017 Mar 14;23(10):1881-1890. doi: 10.3748/wjg.v23.i10.1881.
7
When the liver gets stiff, the tough get moving.当肝脏变硬,坚韧的人就会行动起来。
J Gastroenterol Hepatol. 2020 Jun;35(6):953-959. doi: 10.1111/jgh.14963. Epub 2020 Feb 11.
8
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.香港中文人群中质子磁共振波谱和瞬时弹性成像技术检测非酒精性脂肪性肝病及肝纤维化的流行率:一项基于人群的研究。
Gut. 2012 Mar;61(3):409-15. doi: 10.1136/gutjnl-2011-300342. Epub 2011 Aug 16.
9
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.应用受控衰减参数和肝硬度测量筛查糖尿病患者的非酒精性脂肪性肝病:一项前瞻性队列研究。
Gut. 2016 Aug;65(8):1359-68. doi: 10.1136/gutjnl-2015-309265. Epub 2015 Apr 14.
10
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.应用瞬时弹性成像技术筛查 2 型糖尿病患者的非酒精性脂肪性肝病。
J Gastroenterol Hepatol. 2019 Aug;34(8):1396-1403. doi: 10.1111/jgh.14577. Epub 2019 Jan 21.

引用本文的文献

1
Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050.45岁及以上成年人中与非酒精性脂肪性肝炎相关的肝癌的全球、区域和国家负担:来自全球疾病负担研究(GBD)2021的分析及到2050年的预测
Front Nutr. 2025 Aug 19;12:1651357. doi: 10.3389/fnut.2025.1651357. eCollection 2025.
2
Global, regional, and National burden of metabolic dysfunction-associated steatohepatitis-related liver cancer in older adults: trends and cross-national inequality based on the global burden of disease study 2021.老年人中代谢功能障碍相关脂肪性肝炎相关性肝癌的全球、区域和国家负担:基于2021年全球疾病负担研究的趋势与跨国不平等
Discov Oncol. 2025 Aug 13;16(1):1547. doi: 10.1007/s12672-025-03399-x.
3
Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis.非酒精性脂肪性肝病诊断与监测的非侵入性技术全球趋势:文献计量与可视化分析
J Multidiscip Healthc. 2025 Jul 26;18:4243-4266. doi: 10.2147/JMDH.S525751. eCollection 2025.
4
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.突破界限:解析印度和加拿大儿童中与代谢功能障碍相关的脂肪性肝病
Can Liver J. 2024 Feb 26;7(3):327-337. doi: 10.3138/canlivj-2023-0023. eCollection 2024 Aug.
5
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors.工人中的脂肪肝和高尿酸血症:对代谢功能障碍的联合影响及生活方式因素的作用
Metabolites. 2025 May 9;15(5):318. doi: 10.3390/metabo15050318.
6
Effect of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) on Left Ventricular Mechanics in Patients Without Overt Cardiac Disease: A Systematic Review and Meta-Analysis.代谢功能障碍相关脂肪性肝病(MASLD)对无明显心脏病患者左心室力学的影响:一项系统评价和荟萃分析
J Clin Med. 2025 Apr 15;14(8):2690. doi: 10.3390/jcm14082690.
7
Lipid profile and non-alcoholic fatty liver disease detected by ultrasonography: is systemic inflammation a necessary mediator?血脂谱与超声检查发现的非酒精性脂肪性肝病:全身炎症是必要的介导因素吗?
Ann Med. 2025 Dec;57(1):2480250. doi: 10.1080/07853890.2025.2480250. Epub 2025 Mar 17.
8
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021.1990年至2021年期间,MAFLD、MAFLD相关肝硬化和MASH相关肝癌的全球负担。
Sci Rep. 2025 Feb 27;15(1):7083. doi: 10.1038/s41598-025-91312-5.
9
Global, regional, and national burden of NAFLD in youths and young adults aged 15-39 years, 1990-2021, its attributable risk factors, and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021.1990年至2021年15至39岁青少年和青年非酒精性脂肪性肝病的全球、区域和国家负担、其可归因风险因素以及到2035年的预测:全球疾病负担研究2021的系统分析
Front Nutr. 2025 Jan 28;12:1509232. doi: 10.3389/fnut.2025.1509232. eCollection 2025.
10
Liver diseases: epidemiology, causes, trends and predictions.肝脏疾病:流行病学、病因、趋势及预测
Signal Transduct Target Ther. 2025 Feb 5;10(1):33. doi: 10.1038/s41392-024-02072-z.